Citadel Advisors’s enVVeno Medical NVNO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVNO
KCM
CM
Citadel Advisors's NVNO Position: Q3 2026 in Review
Citadel Advisors opened a new position in enVVeno Medical (NVNO) in Q3 2026: 15,314 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #12701 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NVNO as recently as Q4 2025.
Citadel Advisors first reported a position in NVNO in Q4 2018 and has held it in 16 quarters since. The position peaked at $321K in Q4 2024. 17 funds tracked by Wall St. Rank hold NVNO as of Q3 2026.
- Citadel Advisors held 15,314 shares of enVVeno Medical worth $130K as of Q3 2026.
- enVVeno Medical was a new Citadel Advisors position in Q3 2026.
- enVVeno Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #12701 holding.
- Citadel Advisors first reported a position in enVVeno Medical in Q4 2018 and has held it in 16 quarters since.
- Citadel Advisors's enVVeno Medical position peaked at $321K in Q4 2024.
- 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.